Neuronoff Implants First Patient in DOD-Funded Trial of Injectrode® for Neurogenic Bladder in Spinal Cord Injury

Needle-Delivered Electrode Enables Outpatient Placement and At-Home Stimulation for Spinal Cord Injury Patients With Neurogenic Bladder CLEVELAND and HOUSTON, June 5, 2026 /PRNewswire/ -- Neuronoff, Inc., a clinical-stage neuromodulation company, today announced the first patient implant...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.